Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy

Recruiting now · Not applicable

Conditions studied: Complete Heart Block, Second Degree Atrioventricular Block Möbitz Type II

In brief

Multicenter randomized controlled trial which will include patients with left ventricular ejection fraction \>50% requiring a first implant of a cardiac pacemaker with expected high pacing percentages. Patients will be randomized 1:1 to right ventricular apical pacing vs left septal or deep septal pacing. The primary endpoint will be pacing-induced cardiomyopathy during the first year of follow-up.

Key facts

Study ID
NCT06474819
Run by
Institut d'Investigació Biomèdica de Bellvitge
People needed
326
Starts
2024-07-12
Expected to finish
2027-01-12
Last updated by the study team
2024-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.